Company intelligence / Profile preview

VapoCept

Mountain View, California, United Statesvapocept.com ↗

Ownership: Private
Development stage: Other

Overview

VapoCept is a clinical-stage biotechnology company specializing in the development of inhaled therapies for respiratory diseases. Utilizing a proprietary vaporization platform, the company converts liquid pharmaceuticals into a fine vapor for efficient, deep-lung delivery. This approach is intended to maximize local drug concentration at the site of infection or inflammation while minimizing systemic exposure and side effects. VapoCept's lead programs have focused on delivering repurposed and novel antiviral agents for the treatment of COVID-19 and seasonal influenza.

Therapeutic areas: Infectious DiseasesPulmonology
Modalities: Small moleculeDevice
Industry: Biotech

Partnerships

Panorama Research Institute

Beyond the preview

Go deeper on VapoCept.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VapoCept.

Explore the full profile